Close

Press Releases

Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial

Genzyme Corporation reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also...

Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach

NEW YORK, NY and Whitehouse Station, NJ (October 13, 2010) – Weight Watchers International, Inc., the world's leading provider of weight management services, and Merck, a global healthcare leader, announced today an innovative collaboration focused on fighting obesity. The...

Pfizer to Acquire King Pharmaceuticals, Inc.

Pfizer Inc.and King Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement.  Under the terms of the agreement, Pfizer will acquire King, a diversified specialty pharmaceutical discovery and clinical development company, for $3.6 billion in cash,...

ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the reporting of positive interim clinical data with trastuzumab-DM1 (T-DM1) for first-line treatment of HER2+ metastatic breast cancer in a press release issued by the European...

AJ Precision Components to Exhibit at Interplas 2011

AJ Precision Components will be exhibiting at Interplas 2011 from 27 to 29 September. Come and visit us on stand A58 in hall 4 at the NEC Birmingham, UK.

APR and Labtec enter into exclusive License Agreement with Ferrer International

APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion, distribution and marketing of Donepezil Oral Dispersible Film (ODF) in Spain, Portugal and Germany....

Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria

Baxter International Inc. announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES).  The vaccine was shown to be effective in preventing seasonal influenza and is indicated for prophylaxis of influenza in adults...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read